Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia

NCT00165815 is registered in ClinicalTrials.gov with Eisai Limited as lead sponsor.

NCT NCT00165815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00165815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia
Lead sponsor
Eisai Limited
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2002
Completion date
July 31, 2005
Enrollment
Not reported
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with parkinson's disease